title: Why should cardiologists consider genetic testing for hypertrophic cardiomyopathy?
authors.affiliation: Center for Inherited Heart Disease, Johns Hopkins University, Baltimore, Maryland. Electronic address: djudge@jhmi.edu.
authors.forename: Daniel P
authors.initials: DP
authors.lastname: Judge
mesh_terms: D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002312:Cardiomyopathy, Hypertrophic / Q000235:genetics* / Q000517:prevention & control*; D004110:Diltiazem / Q000627:therapeutic use*; D005260:Female; D006579:Heterozygote; D006801:Humans; D008297:Male; D012518:Sarcomeres / Q000235:genetics*
chemical_list: D002121:Calcium Channel Blockers; D004110:Diltiazem
keywords: cardiomyopathy; genetics; hypertrophy; treatment; trials